Project 4 will focus on defining autoimmune autonomic neuropathy (AAN) as an antibody-mediated disorder and willevaluate features of antibody-mediated autonomic failure that may be relevant to other dysautonomic syndromes. Studiesin this project will provide a direct translational component to the clinical studies of AAN in Project 1 (Dr. Phillip Low)and physiological and serological correlates to the clinical studies of orthostatic tachycardia syndrome (POTS) in Projects1 and 3 (Dr. Michael Joyner).
Showing the most recent 10 out of 66 publications